PNV 2
Alternative Names: PNV-2Latest Information Update: 22 Dec 2021
At a glance
- Originator Purnovate
- Developer ADial Pharmaceuticals; Purnovate
- Class Antineoplastics
- Mechanism of Action Adenosine A1 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Triple negative breast cancer